With the legalization of hemp in the 2018 Farm Bill, an industry was born.
As our veteran team of pharmaceutical industry colleagues became aware of the benefits of cannabinoids, we started discussing the potential of these compounds. After surveying the market, it was clear there were significant and prevalent discrepancies in the quality and purity of the products available.
In fact, a 2019 FDA study found that 90% of CBD products tested did not contain the amount of CBD their labels claimed. Some had more, some had less and some had NONE AT ALL. Some contained ingredients that weren’t listed on the label and many were contaminated or made in facilities that were unclean.
This is horrifying and dangerous.